Eli Lilly plots $2.1B expansion

Eli Lilly plots $2.1B manufacturing expansion at America’s crossroads

Lilly is dipping back into its pocketbook for yet another blockbuster stateside manufacturing expansion after investing $1 billion in an injectables plant in North Carolina in January.

The company plans to invest $2.1 billion in two new manufacturing facilities at LEAP Lebanon Innovation and Research District in Boone County, Indiana, the company announced Wednesday. Lilly is headquartered in the Hoosier State’s capital of Indianapolis.

Lilly said in a release that the facilities would expand the company’s ability to manufacture active ingredients as well as new medicines like genetic medicines. Specifically, the sites will help Lilly respond to heightened demand for its current and future drugs.

Follow us:

Share this article:

Share on linkedin
LinkedIn

Sign Up to our newsletter

Sign up to our newsletter to stay up to date with the latest industry news 

At Easyfairs, we take your privacy seriously and will only use the information we collect or receive about you in accordance with our privacy policy. If you change your mind you can unsubscribe at any time.